World’s First Portable Fingerprint Drug Test Launched
By LabMedica International staff writers Posted on 13 Sep 2017 |

Image: The fingerprint sample collection cartridge and the portable Reader 1000 analysis unit for drug screening (Photo courtesy of Intelligent Fingerprinting).
The world’s first portable fingerprint-based drug screening system has been launched and is available now. The revolutionary system is hygienic and easy-to-use, collecting fingerprint samples in just five seconds and delivering simultaneous screening results in less than ten minutes for the four main drug groups: cocaine, opiates, cannabis and amphetamines.
Initial applications for the system include support for drug testing programs within drug rehabilitation, workplace and criminal justice arenas. Organizations using the new system, which have previously been reliant on collecting saliva and urine samples for drug screening, will benefit from the simplicity and improved hygiene of fingerprint drug tests. Those being tested appreciate the system’s dignified and non-invasive collection method.
The screening system is being launched by Intelligent Fingerprinting (Cambridge, UK). The technology which consists of a fingerprint sample collection cartridge and the portable Reader 1000 analysis unit works by analyzing the tiny traces of sweat contained in a fingerprint to detect drugs and drug metabolites. The four drug groups detected by Drug Screening Cartridge cover the majority of mainstream drug misuse, ensuring that the company’s new drug testing system can support a broad range of drug screening requirements immediately. Collecting a fingerprint sweat sample on the cartridge takes just five seconds. The cartridge is then inserted into a reader that analyses the fingerprint sweat to provide a positive or negative result for each drug in the test in less than 10 minutes.
Jerry Walker, PhD, CEO of Intelligent Fingerprinting, said, “Our portable fingerprint drug test means that organizations can now screen for drug use almost anywhere at any time. It only takes a few seconds to collect a fingerprint for analysis, and our revolutionary technology offers a much more hygienic and dignified means of testing compared with conventional drug tests that require bio-hazardous samples such as urine or saliva. Following successful UK market trials and validation, it’s clear that fingerprint samples are not only much easier to collect and process, but also deliver when it comes to the rigorous analysis required for drug use diagnostics.”
Related Links:
Intelligent Fingerprinting
Initial applications for the system include support for drug testing programs within drug rehabilitation, workplace and criminal justice arenas. Organizations using the new system, which have previously been reliant on collecting saliva and urine samples for drug screening, will benefit from the simplicity and improved hygiene of fingerprint drug tests. Those being tested appreciate the system’s dignified and non-invasive collection method.
The screening system is being launched by Intelligent Fingerprinting (Cambridge, UK). The technology which consists of a fingerprint sample collection cartridge and the portable Reader 1000 analysis unit works by analyzing the tiny traces of sweat contained in a fingerprint to detect drugs and drug metabolites. The four drug groups detected by Drug Screening Cartridge cover the majority of mainstream drug misuse, ensuring that the company’s new drug testing system can support a broad range of drug screening requirements immediately. Collecting a fingerprint sweat sample on the cartridge takes just five seconds. The cartridge is then inserted into a reader that analyses the fingerprint sweat to provide a positive or negative result for each drug in the test in less than 10 minutes.
Jerry Walker, PhD, CEO of Intelligent Fingerprinting, said, “Our portable fingerprint drug test means that organizations can now screen for drug use almost anywhere at any time. It only takes a few seconds to collect a fingerprint for analysis, and our revolutionary technology offers a much more hygienic and dignified means of testing compared with conventional drug tests that require bio-hazardous samples such as urine or saliva. Following successful UK market trials and validation, it’s clear that fingerprint samples are not only much easier to collect and process, but also deliver when it comes to the rigorous analysis required for drug use diagnostics.”
Related Links:
Intelligent Fingerprinting
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Molecular Diagnostics
view channel
POC Oral Swab Test to Increase Chances of Pregnancy in IVF
Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Qiagen Acquires NGS Analysis Software Company Genoox
QIAGEN (Venlo, the Netherlands) has signed a definitive agreement to acquire Genoox (Tel Aviv, Israel), a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and... Read more
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more